Riskpilot← Back to searchSign inGet full accessCanngros ApS
APSActiveCVR 39039451Lejrvej 9, 1.Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20171 employeeswww.canngros.dk
Revenue 2024
DKK -187K
-110% vs 2023
EBITDA margin
100.2%
-136% vs 2023
Equity ratio
52.4%
Financial strength
Net profit 2024
DKK -279K
-172% vs 2023
| Revenue | DKK -187K | -110% |
| EBITDA | DKK -187K | -136% |
| Net profit | DKK -279K | -172% |
| Total assets | DKK 2,3M | -9% |
| Equity | DKK 1,2M | -19% |
| Employees | 1 | — |
Legal name
Canngros ApS
CVR number
39039451
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
27. oktober 2017
Share capital
DKK 50.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at udvikle, producere og forhandle lægemidler og hermed forbundet virksomhed.
Address
Lejrvej 9, 1.
Phone
+4531770060
Email
info@stenocare.com
Website
www.canngros.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 115 | 284 | 356 | 1.807 | 1.905 | 1.857 | -187 |
| Staff expenses | -94 | -90 | -150 | -151 | -1.021 | -1.343 | -0 |
| EBITDA | 21 | 194 | 206 | 1.656 | 883 | 514 | -187 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 21 | 194 | 206 | 1.656 | 883 | 514 | -187 |
| Net financials | -7 | -3 | -9 | -11 | -21 | -14 | -92 |
| Profit before tax | 14 | 192 | 197 | 1.645 | 863 | 500 | -279 |
| Tax | 3 | 43 | 45 | 362 | 193 | 110 | -0 |
| Net profit | 11 | 149 | 152 | 1.282 | 670 | 390 | -279 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 723 | 1.309 | 853 | 1.319 | 2.566 | 2.522 | 2.303 |
| Equity | 61 | 210 | 361 | 427 | 1.096 | 1.486 | 1.207 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 663 | 1.099 | 492 | 892 | 1.470 | 1.036 | 814 |
| Total debt | 663 | 1.099 | 492 | 892 | 1.470 | 1.036 | 814 |
EBITDA margin
-18724700.0%
This company
15.8%
Market median
-118510859% vs market
20182024
Equity ratio
52.4%
This company
38.2%
Market median
+37% vs market
20182024
Return on equity
-23.1%
This company
18.4%
Market median
-226% vs market
20182024
Net profit margin
-27891700.0%
This company
8.1%
Market median
-344342075% vs market
20182024
Asset turnover
-0.08×
This company
1.12×
Market median
-107% vs market
20182024
Debt / equity
0.91×
This company
0.62×
Market median
+47% vs market
20182024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2017-10-27 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
LC Management | Management | 2022 | — | — |
HL Management | Management | 2017 | — | — |
JK Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
TS Management | Management | 2025 | — | — |
KØ Founder | Founder | 2017 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
STENOCARE A/S | Company | 100.0% | 100.0% | 2025 |
Schejbel Holding ApS | Company | 33.3% | 33.3% | 2018 |
Ethican ApS | Company | 33.3% | 33.3% | 2017 |
DANCANN PHARMA A/S | Company | 100.0% | 100.0% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SC-Founders Holding ApS
Canngros ApS Board members of Canngros ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Louise Conradsen | Management | 0 companies |
| Henrik Lund Uth | Management | 0 companies |
| Jeppe Krog Rasmussen | Chief Executive Officer | 0 companies |
| Thomas Skovlund Schnegelsberg | Management | 0 companies |
| Kristian Østergaard Nielsen | Founder | 0 companies |